Involvement of the κ-opioid receptor in nitrous oxide-induced analgesia in mice
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Nitrous oxide (N2O)-induced analgesia is thought to be mediated by endogenous opioids. We previously showed that the μ-opioid receptor is not required for the analgesic action of N2O in mice using a gene knockout approach. In this study, we examined the effect of κ- (KOP)- or δ-opioid receptor (DOP)-selective antagonists on N2O-induced analgesia. The analgesic effect of N2O was evaluated using a writhing test. Male C57BL/6 mice aged 7–8 weeks were assigned to control, N2O, KOP agonist, and DOP agonist groups. According to the group assignment, mice were pretreated with a KOP antagonist, nor-binaltorphimine (nor-BNI), a DOP antagonist, naltrindole hydrochloride (NTI), a KOP agonist U50488, and a DOP agonist SNC80. Mice in the control, KOP agonist, and DOP agonist groups were exposed to 25% oxygen/75% nitrogen for 30 min, and mice in the N2O group were exposed to 25% oxygen/75% N2O for 30 min. Nor-BNI [10 mg kg–1, subcutaneously (s.c.)] significantly suppressed the analgesic effect of N2O and U50488. In contrast, NTI (10 mg kg–1 s.c.) did not significantly affect the analgesic action of N2O, but almost completely inhibited the analgesic effect of SNC80. These results suggest that KOP plays an important role in the analgesic effect of N2O in mice.
- Berkowitz B, Ngai S, Finck A. Nitrous oxide “analgesia”: resemblance to opiate action. Science. 1976;194:967–8. CrossRef
- Fujinaga M, Maze M. Neurobiology of nitrous oxide-induced antinociceptive effects. Mol Neurobiol. 2002;25:167–89. CrossRef
- Sanders R, Weimann J, Maze M. Biologic effects of nitrous oxide: a mechanistic and toxicologic review. Anesthesiology. 2008;109:707–22. CrossRef
- Emmanouil D, Dickens A, Heckert R, Ohgami Y, Chung E, Han S, Quock R. Nitrous oxide-antinociception is mediated by opioid receptors and nitric oxide in the periaqueductal gray region of the midbrain. Eur Neuropsychopharmacol. 2008;18:194–9. CrossRef
- Koyama T, Mayahara T, Wakamatsu T, Sora I, Fukuda K. Deletion of μ-opioid receptor in mice does not affect the minimum alveolar concentration of volatile anaesthetics and nitrous oxide-induced analgesia. Br J Anaesth. 2009;103:744–9. CrossRef
- Portoghese P, Lipkowski A, Takemori A. Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists. Life Sci. 1987;40:1287–92. CrossRef
- Takemori A, Ho B, Naeseth J, Portoghese P. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther. 1988;246:255–8.
- Portoghese P, Sultana M, Takemori A. Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist. Eur J Pharmacol. 1988;146:185–6. CrossRef
- Vonvoigtlander P, Lahti R, Ludens J. U-50, 488: a selective and structurally novel non-mu (kappa) opioid agonist. J Pharmacol Exp Ther. 1983;224:7–12.
- Bilsky E, Calderon S, Wang T, Bernstein R, Davis P, Hruby V, McNutt R, Rothman R, Rice K, Porreca F. SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther. 1995;273:359–66.
- Quock R, Best J, Chen D, Vaughn L, Portoghese P, Takemori A. Mediation of nitrous oxide analgesia in mice by spinal and supraspinal κ-opioid receptors. Eur J Pharmacol. 1990;175:97–100. CrossRef
- Branda E, Ramza J, Cahill F, Tseng L, Quock R. Role of brain dynorphin in nitrous oxide antinociception in mice. Pharmacol Biochem Behav. 2000;65:217–21. CrossRef
- Kingery W, Sawamura S, Agashe G, Davies M, Clark J, Zimmer A. Enkephalin release and opioid receptor activation does not mediate the antinociceptive or sedative/hypnotic effects of nitrous oxide. Eur J Pharmacol. 2001;427:27–35. CrossRef
- Georgiev S, Kohno T, Ikoma M, Yamakura T, Baba H. Nitrous oxide inhibits glutamatergic transmission in spinal dorsal horn neurons. Pain. 2008;134:24–31. CrossRef
- Mueller J, Quock R. Contrasting influences of 5-hydroxytryptamine receptors in nitrous oxide antinociception in mice. Pharmacol Biochem Behav. 1992;41:429–32. CrossRef
- Mukaida K, Shichino T, Fukuda K. Nitrous oxide increases serotonin release in the rat spinal cord. J Anesth. 2007;21:433–5. CrossRef
- Yamakura T, Harris R. Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol. Anesthesiology. 2000;93:1095–101. CrossRef
- Gruss M, Bushell T, Bright D, Lieb W, Mathie A, Franks N. Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol. 2004;65:443–52. CrossRef
- Pan Z. μ-Opposing actions of the κ-opioid receptor. Trends Pharmacol Sci. 1998;19:94–8. CrossRef
- Fields H. State-dependent opioid control of pain. Nat Rev Neurosci. 2004;5:565–75. CrossRef
- Santos M, Kuncar V, Martínez-Taboada F, Tendillo F. Large concentrations of nitrous oxide decrease the isoflurane minimum alveolar concentration sparing effect of morphine in the rat. Anesth Analg. 2005;100:404–8. CrossRef
- Endoh T, Matsuura H, Tanaka C, Nagase H. Nor-binaltorphimine: a potent and selective κ-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther. 1992;316:30–42.
- Ossipov M, Kovelowski C, Vanderah T, Porreca F. Naltrindole, an opioid δ antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat. Neurosci Lett. 1994;181:9–12. CrossRef
- Involvement of the κ-opioid receptor in nitrous oxide-induced analgesia in mice
Journal of Anesthesia
Volume 24, Issue 2 , pp 297-299
- Cover Date
- Print ISSN
- Online ISSN
- Springer Japan
- Additional Links
- Nitrous oxide
- Opioid receptor
- Industry Sectors